Fisetin has been shown to suppress autophagy in hepatocellular carcinoma by activating PI3K/AKT/mTOR and inhibiting AMPK, resulting in autophagy inhibition and increased apoptosis. Here, MTOR is linked to hepatocellular carcinoma.